Author: "Kim, Uh Jin" / Journal: antimicrobial agents and chemotherapy - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Kim, Uh Jin"' showing total 4 results

Start Over Author "Kim, Uh Jin" Journal antimicrobial agents and chemotherapy

Author: Kim, Seong Eun, primary, Kim, Hee Kyung, additional, Choi, Su-Mi, additional, Yu, Yohan, additional, Kim, Uh Jin, additional, Darboe, Kalifa Sanneh, additional, Kang, Seung-Ji, additional, Park, Kyung-Hwa, additional, Kang, Gaeun, additional, Kim, Young Ran, additional, Rhee, Joon Haeng, additional, Jung, Sook-In, additional, and Jang, Hee-Chang, additional
Published: 2019
Full Text: View/download PDF

Author: Jang, Mi-Ok, primary, Jang, Hee-Chang, additional, Kim, Uh Jin, additional, Ahn, Joon Hwan, additional, Kang, Seung-Ji, additional, Jung, Sook-In, additional, Shin, Hee-Young, additional, and Park, Kyung-Hwa, additional
Published: 2014
Full Text: View/download PDF

Author: Kim, Seong Eun, Kim, Hee Kyung, Choi, Su-Mi, Yu, Yohan, Kim, Uh Jin, Darboe, Kalifa Sanneh, Kang, Seung-Ji, Park, Kyung-Hwa, Kang, Gaeun, Kim, Young Ran, Rhee, Joon Haeng, Jung, Sook-In, and Jang, Hee-Chang
Abstract: The mortality rate associated with Vibrio vulnificussepsis remains high. An in vitrotime-kill assay revealed synergism between tigecycline and ciprofloxacin. The survival rate was significantly higher in mice treated with tigecycline plus ciprofloxacin than in mice treated with cefotaxime plus minocycline. Thus, combination treatment with tigecycline-ciprofloxacin may be an effective novel antibiotic regimen for V. vulnificussepsis.
Published: 2019
Full Text: View/download PDF

Author: Kim SE, Kim HK, Choi SM, Yu Y, Kim UJ, Darboe KS, Kang SJ, Park KH, Kang G, Kim YR, Rhee JH, Jung SI, and Jang HC
Subjects: Animals, Cefotaxime pharmacology, Colony Count, Microbial, Disease Models, Animal, Drug Synergism, Drug Therapy, Combination, Female, Humans, Mice, Mice, Inbred BALB C, Microbial Sensitivity Tests, Minocycline pharmacology, Sepsis microbiology, Sepsis mortality, Sepsis pathology, Survival Analysis, Vibrio Infections microbiology, Vibrio Infections mortality, Vibrio Infections pathology, Vibrio vulnificus growth & development, Anti-Bacterial Agents pharmacology, Ciprofloxacin pharmacology, Sepsis drug therapy, Tigecycline pharmacology, Vibrio Infections drug therapy, Vibrio vulnificus drug effects
Abstract: The mortality rate associated with Vibrio vulnificus sepsis remains high. An in vitro time-kill assay revealed synergism between tigecycline and ciprofloxacin. The survival rate was significantly higher in mice treated with tigecycline plus ciprofloxacin than in mice treated with cefotaxime plus minocycline. Thus, combination treatment with tigecycline-ciprofloxacin may be an effective novel antibiotic regimen for V. vulnificus sepsis., (Copyright © 2019 American Society for Microbiology.)
Published: 2019
Full Text: View/download PDF

Books, media, physical & digital resources

Searchworks